- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07892079
Effects of Motor Control Exercises With and Without Pressure Biofeedback in Recurrent Low Back Pain (MCE) (yes)
Effects of Motor Control With and Without Pressure Biofeedback-Guided Training on Pain, Transversus Abdominis Activation and Disability in Patients With Recurrent Low Back Pain
This study aims to compare the effects of Motor Control Exercises (MCE) with and without Pressure Biofeedback-Guided Training in patients with recurrent low back pain. It will evaluate the effectiveness of both interventions in reducing pain, improving Transversus abdominis (TrA) muscle activation, and decreasing disability. The study will determine whether adding pressure biofeedback to motor control exercises provides better clinical outcomes than motor control exercises alone.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- University of Management & Technology
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Patients aged 18-45 years with recurrent low back pain
- Both male and female participants
- Mild to moderate low back pain with a NPRS Scale score of 3-6 out of 10
- History of at least two episodes of low back pain within the past 12 months
- Absence of radiating pain below the gluteal fold
- Ability to perform the Abdominal Drawing-In Maneuver (ADIM)
Exclusion Criteria:
- Specific low back pain attributable to identifiable pathological conditions
- Active lumbar radiculopathy accompanied by neurological deficits
- Referred or radiating pain extending below the gluteal fold
- Diagnosed spinal conditions, including disc herniation, spinal stenosis,
- Medical conditions potentially associated with low back pain e.g tumors
- History of surgery for low back pain within the past 12 months
- Pregnancy
- Current participation in another physiotherapy or rehabilitation program
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Motor Control Training with Pressure Bio-feedback
|
Participants will receive 45-minute sessions comprising a 5-minute warm-up, 35-minute Motor Control Exercises (MCE), and 5-minute cool-down, guided by Pressure Biofeedback (PBU). Weeks 1-2: ADIM, diaphragmatic breathing, multifidus activation, and heel slides (2-3 sets × 10 repetitions). Weeks 3-4: Straight leg raises, double-leg lowering, bridging, and quadruped arm/leg extensions (3 sets × 8-10 repetitions). Weeks 5-6: Standing ADIM, partial squats, planks, and sit-to-stand exercises (3 sets × 10 repetitions; planks 20-45 seconds). |
|
Aktiv komparator: Motor Control Training
|
Participants will receive the same 45-minute Motor Control Exercise (MCE) program as in experimental group, including warm-up, phased exercises (Weeks 1-6), and cool-down, with identical sets, repetitions, hold times, rest intervals, and progression criteria, but without Pressure Biofeedback (PBU). Standardized verbal instructions and tactile cues (TrA palpation) will guide muscle activation. The same physiotherapist will supervise both groups, with exercise completion and adverse events recorded in session logs. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Numeric Pain Rating Scale
Tidsram: Baseline, 3 weeks and 6 weeks post treatment
|
Pain intensity will be assessed using the Numeric Pain Rating Scale, an 11-point scale ranging from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain. Scores of 1-3 indicate mild pain, 4-6 indicate moderate pain, and 7-10 indicate severe pain. Higher scores indicate greater pain intensity and a worse outcome, while lower scores indicate less pain and a better outcome. |
Baseline, 3 weeks and 6 weeks post treatment
|
|
Revised Oswestry Disability Questionnaire
Tidsram: Baseline, 3 weeks and 6 weeks post treatment
|
The Revised Oswestry Disability Questionnaire is a valid and reliable 10-item questionnaire. Each item is scored 0-5, with total disability expressed as a percentage: 0-20% (minimal), 21-40% (moderate), 41-60% (severe), 61-80% (crippled/severe functional limitation), and 81-100% (very severe disability). Higher scores indicate greater disability. |
Baseline, 3 weeks and 6 weeks post treatment
|
|
Rehabilitative Ultrasound Imaging
Tidsram: Baseline, 3 weeks and 6 weeks post treatment
|
Rehabilitative Ultrasound Imaging (RUSI) is a non-invasive, reliable technique used to assess deep trunk muscle morphology, thickness, and activation. Transversus Abdominis (TrA) activation will be evaluated by measuring muscle thickness at rest and during contraction. Changes in muscle thickness will serve as an indirect indicator of muscle activation and lumbopelvic stability. |
Baseline, 3 weeks and 6 weeks post treatment
|
|
Pressure Biofeedback
Tidsram: Baseline, 3 weeks and 6 weeks post treatment
|
The Pressure Biofeedback Unit (PBU) is a non-invasive device consisting of an inflatable pressure cell and gauge that provides visual feedback to improve lumbopelvic control during motor control exercises. It helps enhance abdominal muscle recruitment, reduce lumbopelvic instability, and improve movement control in patients with chronic low back pain. |
Baseline, 3 weeks and 6 weeks post treatment
|
Samarbetspartners och utredare
Publikationer och användbara länkar
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- RE-167-2026
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Tidsram för IPD-delning
6 months after the publication of the manuscript.
Kriterier för IPD Sharing Access
The data can be requested from the corresponding author
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
- SAV
- ICF
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .